Sonographic Comparison of Pancreatic Echogenicity in Diabetics and Non-Diabetics with Relation to Disease Duration
Indus Journal of Bioscience Research · 08.04.2026 · 4 (S1) · 6-20
DOI: 10.70749/ijbr.v4is1.3114 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indus Journal of Bioscience Research, online erschienen am 08.04.2026. Verfasst von Amina Mehmood und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Sonographic comparison of pancreatic echogenicity between diabetics and non-diabetics has emerged as a valuable non-invasive approach to understand structural pancreatic changes in diabetes mellitus. Pancreatic echogenicity refers to the brightness of pancreatic tissue on ultrasound relative to adjacent organs, particularly the liver. Diabetes, affecting over 537 million adults globally, is associated with progressive morphological alterations in the pancreas including fatty infiltration, fibrosis, and atrophy. These structural changes may correlate with disease duration and severity, yet remain relatively underexplored in clinical imaging literature.
Objective
To compare pancreatic echogenicity patterns between diabetic and non-diabetic individuals and examine their correlation with diabetes duration using ultrasonography. Methodology: This cross-sectional study was conducted at Waqas Hospital using a non-probability purposive sampling technique. A total of 139 participants were enrolled, comprising both diabetic patients and non-diabetic controls aged 35 years and above. Diabetic participants were stratified according to disease duration into early (1–6 years), moderate (7–15 years), and long duration (>15 years) groups. All participants underwent standardized abdominal ultrasonography using a 3.5–5 MHz transducer to evaluate pancreatic echogenicity patterns.
Results
A total of 139 participants were included in the final analysis. The sample comprised 76 males (54.7%) and 63 females (45.3%). Age distribution showed 30 participants (21.6%) in the 36–45 years’ category, 60 (43.2%) in 46–55 years, and 49 (35.3%) aged ≥56 years. Among diabetics (n=90), 24 participants (17.3%) had Early duration (1–6 years), 45 (32.4%) had Moderate duration (7–15 years), and 21 (15.1%) had long duration (>15 years) diabetes. Severe echogenicity was the most prevalent category, observed in 61 participants (43.9%), and followed by Mild echogenicity in 52 (37.4%) and Moderate echogenicity in 26 (18.7%). A strong progressive association was observed between diabetes duration and echogenicity severity: Non-diabetic and Early duration groups predominantly exhibited Mild echogenicity, while Moderate and Long duration groups showed predominantly severe echogenicity. Echotexture analysis revealed a Homogeneous pattern in 78 participants (56.1%) and a Heterogeneous pattern in 61 participants (43.9%). A perfect association was found between echotexture and echogenicity, with all Homogeneous cases showing Mild or Moderate echogenicity and all Heterogeneous cases showing Severe echogenicity. Cross-tabulation analyses demonstrated that longer diabetes duration was associated with increasingly severe pancreatic measurements across all three segments (head, body, and tail). Gender analysis revealed that females predominated in the long duration diabetes group (18 out of 21), while males were more prevalent in non-diabetic and early duration categories.
Conclusion
The study reveals a significant correlation between longer diabetes duration and increased severity of pancreatic echogenicity, heterogeneous echotexture, and reduced pancreatic dimensions across all segments. These structural changes reflect underlying pathological processes including pancreatic steatosis, fibrosis, and atrophy that progress with disease duration. A perfect association was observed between echotexture and echogenicity, confirming their interconnected role in reflecting pancreatic parenchymal alterations. These findings validate pancreatic ultrasonography as a valuable non-invasive tool for monitoring diabetes-related structural progression. Routine echogenicity assessment may help identify patients at risk for advanced pancreatic damage and guide personalized therapeutic interventions.
Zitieren
APA
Mehmood, A., Nirmyan, M., Noman, A., Iqbal, A., Niaz, S., Manahil, H., & Zafar, S. (2026). Sonographic Comparison of Pancreatic Echogenicity in Diabetics and Non-Diabetics with Relation to Disease Duration. Indus Journal of Bioscience Research, 4(S1), 6-20. https://doi.org/10.70749/ijbr.v4is1.3114
Vancouver
Mehmood A, Nirmyan M, Noman A, Iqbal A, Niaz S, Manahil H, et al. Sonographic Comparison of Pancreatic Echogenicity in Diabetics and Non-Diabetics with Relation to Disease Duration. Indus Journal of Bioscience Research. 2026;4(S1):6-20. doi:10.70749/ijbr.v4is1.3114
BibTeX
@article{Mehmood2026,
author = {Mehmood, Amina and Nirmyan, Muhammad and Noman, Ali and Iqbal, Aliza and Niaz, Sunaina and Manahil, Humna and Zafar, Saba},
title = {Sonographic Comparison of Pancreatic Echogenicity in Diabetics and Non-Diabetics with Relation to Disease Duration},
journal = {Indus Journal of Bioscience Research},
year = {2026},
volume = {4},
number = {S1},
pages = {6--20},
doi = {10.70749/ijbr.v4is1.3114}
}
EUVIMED